← All trials
NCT05422027
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 25, 2022
- Primary completion
- Jun 30, 2025
- Completion date
- Dec 31, 2025
- First posted
- Jun 16, 2022
- Last posted
- Aug 17, 2022
- Enrollment
- 42
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Sun Yat-Sen UniversityLead sponsor
- Sun Yat-Sen UniversityOverall official - principal investigator
- Sun Yat-Sen UniversitySponsor investigator
- Antengene CorporationCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.